Your browser doesn't support javascript.
loading
The beneficial health effects of puerarin in the treatment of cardiovascular diseases: from mechanisms to therapeutics.
Wan, Qiang; Lu, Qiwen; Luo, Sang; Guan, Chengyan; Zhang, Hao.
Afiliação
  • Wan Q; Affiliated Hospital of Jiangxi University of Chinese Medicine, 445 Bayi Avenue, Nanchang, 330006, China. wanqiang1@jxutcm.edu.cn.
  • Lu Q; Clinical Medical College, Jiangxi University of Chinese Medicine, 445 Bayi Avenue, Nanchang, 330006, China. wanqiang1@jxutcm.edu.cn.
  • Luo S; Graduate School, Jiangxi University of Chinese Medicine, 1688 Meiling Avenue, Nanchang, 330004, China.
  • Guan C; Graduate School, Jiangxi University of Chinese Medicine, 1688 Meiling Avenue, Nanchang, 330004, China.
  • Zhang H; Graduate School, Jiangxi University of Chinese Medicine, 1688 Meiling Avenue, Nanchang, 330004, China.
Naunyn Schmiedebergs Arch Pharmacol ; 397(10): 7273-7296, 2024 10.
Article em En | MEDLINE | ID: mdl-38709267
ABSTRACT
Cardiovascular diseases (CVDs) are the leading causes of death globally that seriously threaten human health. Although novel western medicines have continued to be discovered over the past few decades to inhibit the progression of CVDs, new drug research and development for treating CVDs with less side effects and adverse reactions are continuously being desired. Puerarin is a natural product found in a variety of medicinal plants belonging to the flavonoid family with potent biological and pharmacological activities. Abundant research findings in the literature have suggested that puerarin possesses a promising prospect in treating CVDs. In recent years, numerous new molecular mechanisms of puerarin have been explored in experimental and clinical studies, providing new evidence for this plant metabolite to protect against CVDs. This article systematically introduces the history of use, bioavailability, and various dosage forms of puerarin and further summarizes recently published data on the major research advances and their underlying therapeutic mechanisms in treating CVDs. It may provide references for researchers in the fields of pharmacology, natural products, and internal medicine.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Isoflavonas Limite: Animals / Humans Idioma: En Revista: Naunyn Schmiedebergs Arch Pharmacol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Isoflavonas Limite: Animals / Humans Idioma: En Revista: Naunyn Schmiedebergs Arch Pharmacol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: Alemanha